Crowding: 0 of 15 resolved names held by 3+ tracked funds · Crowded share not computed: this book does not reconcile (positions sum to 172% of the reported total). · Issuers are matched on normalised name (~10% measured error each way), so crowding and overlap figures are floors. How this is measured → · full readout →
Ranked by holdings overlap blended with size, leverage, yield and fee profile within the same asset class.
Issuers are matched on normalised name (~10% measured error each way), so crowding and overlap figures are floors. How this is measured →
| Audax Credit BDC Inc. profile-based only, no holdings overlap | 83% similarƒ |
| Pimco Capital Solutions BDC Corp. profile-based only, no holdings overlap | 76% similarƒ |
| TCW Star Direct Lending LLC profile-based only, no holdings overlap | 74% similarƒ |
| Runway Growth Finance Corp. profile-based only, no holdings overlap | 71% similarƒ |
| Stellus Private Credit BDC profile-based only, no holdings overlap | 69% similarƒ |
16 positions as of 2026-03-31 · Schedule of Investments (SEC BDC Data Sets).
These positions sum to 172% of the fund's reported total, so individual values are not exact. This filer tags its Schedule of Investments with company-specific XBRL concepts we haven't mapped yet. Names and relative sizes are indicative; the figures are not.
| Company | Fair value | Weight |
|---|---|---|
| Cannabis | $201M | 41.9% |
| STAT Buyer, LLC | $58M | 12.1% |
| Justice Cannabis Company | $43M | 8.9% |
| Story of Maryland LLC | $31M | 6.5% |
| Story of Natures Medicine LLC | $21M | 4.4% |
| BCIS AH Borrower LLC Insurance | $20M | 4.1% |
| Devi Holdings Inc. | $18M | 3.7% |
| High End Holdings LLC | $16M | 3.2% |
| Story of Ohio LLC | $15M | 3.0% |
| High End Holdings LLC | $14M | 2.9% |
| Standard Wellness Company, LLC | $11M | 2.4% |
| Cresco Labs, LLC | $10M | 2.1% |
| Theratrue, Inc. | $8M | 1.6% |
| DMA Holdings (MA), LLC | $5M | 1.1% |
| Trulieve Cannabis Corp. | $5M | 1.0% |
| MI Opportunity Fund I, LLC | $5M | 1.0% |
Not shown: this filing states no industry on positions holding 96% of the book's value, so the bars would chart that gap rather than the portfolio.
Not shown: with fewer than 10% of positions stating a tranche, the mix would describe which rows happen to be tagged, not the book.
Crowded share not computed: this book does not reconcile (positions sum to 172% of the reported total).
0 of 15 resolved names are held by 3+ tracked funds · Issuers are matched on normalised name (~10% measured error each way), so crowding and overlap figures are floors. How this is measured →
Source: AltsVault · SEC filings
see which of these names are crowded →
Fair value against cost across this fund's filed Schedule of Investments — read off the marks the filer itself reported, not a rating.
Over 16 debt positions, $480M at fair value · 0 trimmed, 0 excluded (equity or no usable cost).
Not shown: neither a filed label nor the filer's own identifier text classifies seniority on any position in this book, so the mix would chart an empty label rather than the portfolio.
Debt positions are identified by a filed principal amount — a proxy measured 82% precise against positions that also state an instrument (18% carry an equity-side label instead). Marks outside 0.01×–2.00× of cost are held out of the aggregates above as extraction artifacts, not credit opinion. · This book doesn't reconcile to the fund's reported total within 10% — treat marks as approximate.
Source: AltsVault · SEC filings · as of 2026-03-31
26 metrics reported by this fund.